Company intelligence / Profile preview

Surecare Pharma

New Delhi, Delhi, India
Ownership
Private
Development stage
Other
01

Overview

Surecare Pharma manufactures over 50 products in dermatology and other therapeutic areas, primarily focused on the Northern Indian market and claims several innovative formulations. All products are manufactured in WHO GMP-certified units. Publicly available detailed clinical study results or regulatory filings are not provided.

Therapeutic areas
DermatologyOther
Modalities
Small molecule
Industry
Biotech
02

Drug pipeline

2 assets

Acfree

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Surecare Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Surecare Pharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call